-
A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview.
Potter JS, Prather K, Kropp FB, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemporary Clinical Trials 2010;31(2):185-188.
-
Teaching condom use skills: Practice is superior to observation.
Calsyn DA, Hatch-Maillette MA, Doyle SR, Cousins SJ, Chen T, Godinez M. Teaching condom use skills: Practice is superior to observation. Substance Abuse 2010;31(4):231-239
-
The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation.
Abraham AJ, Knudsen HK, Rothrauff TC, Roman PM. The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation. Journal of Substance Abuse Treatment 2010;38(3):275-283.
-
A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology.
Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemporary Clinical Trials 2010;31(2):189-199.
-
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study.
Chakrabarti A, Woody GE, Griffin ML, Subramaniam GA, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study. Drug and Alcohol Dependence 2010;107(2-3):253-256.
-
Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA’s Clinical Trials Network.
Hien DA, Jiang H, Campbell ANC, Hu M, Miele GM, Cohen LR, Brigham GS, Capstick C, Kulaga A, Robinson JA, Suarez-Morales L, Nunes EV. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. American Journal of Psychiatry 2010;167(1):95-101.
-
Gender differences in the rates and and correlates of HIV risk behaviors among drug abusers.
Brooks AJ, Meade CS, Potter JS, Lokhnygina Y, Calsyn DA, Greenfield SF. Gender differences in the rates and and correlates of HIV risk behaviors among drug abusers. Substance Use & Misuse 2010;45(14):2444-2469.
-
External pressure, motivation, and treatment outcome among pregnant substance-abusing women.
Ondersma SJ, Winhusen TJ, Lewis DF. External pressure, motivation, and treatment outcome among pregnant substance-abusing women. Drug and Alcohol Dependence 2010;107(2-3):149-153.
-
Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults.
Bogenschutz MP, Abbott P, Kushner R, Tonigan JS, Woody GE. Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults. Journal of Addiction Medicine 2010;4(4):211-216.
-
Conducting clinical research with prescription opioid dependence: Defining the population.
Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer JA, Ling W. Conducting clinical research with prescription opioid dependence: Defining the population. American Journal on Addictions 2010;19(2):141-146.